Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk G van der Poel

Showing results (1-10 of 340) with videos related to

Pageof 34
Sort By:
European Urology|March 14, 2009
Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancerHenk G van der Poel
European Urology|April 8, 2009
Chemical castration and survival in low-risk prostate cancerHenk G van der Poel
European Urology|August 9, 2007
Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancerHenk G van der Poel
European Urology|April 24, 2007
Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomyHenk G van der Poel
European Urology|July 1, 2008
Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patientsHenk G van der Poel
European Urology|May 27, 2008
Editorial comment on: Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial CEFUB)Henk G van der Poel
European Urology|March 17, 2020
Re: Apalutamide and Overall Survival in Non-metastatic Castration-resistant Prostate CancerHenk G van der Poel
European Urology|October 14, 2009
Words of wisdom. Re: Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Tran C, Ouk S, Clegg NJ, et alHenk G van der Poel
BJU International|September 27, 2014
Extent of lymph node metastasesHenk G van der Poel
European Urology|April 22, 2006
Foreseeing cancer metastasesHenk G van der Poel
Pageof 34

Showing results (1-10 of 340) with videos related to

Sort By:
Pageof 34
European Urology|March 14, 2009
Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancerHenk G van der Poel
European Urology|April 8, 2009
Chemical castration and survival in low-risk prostate cancerHenk G van der Poel
European Urology|August 9, 2007
Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancerHenk G van der Poel
European Urology|April 24, 2007
Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomyHenk G van der Poel
European Urology|July 1, 2008
Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patientsHenk G van der Poel
European Urology|May 27, 2008
Editorial comment on: Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial CEFUB)Henk G van der Poel
European Urology|March 17, 2020
Re: Apalutamide and Overall Survival in Non-metastatic Castration-resistant Prostate CancerHenk G van der Poel
European Urology|October 14, 2009
Words of wisdom. Re: Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Tran C, Ouk S, Clegg NJ, et alHenk G van der Poel
BJU International|September 27, 2014
Extent of lymph node metastasesHenk G van der Poel
European Urology|April 22, 2006
Foreseeing cancer metastasesHenk G van der Poel
Pageof 34